Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer (Q46701849)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer |
scientific article |
Statements
1 reference
Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer (English)
1 reference
Gernot Hudelist
1 reference
Wolfgang J Köstler
1 reference
Klaus Czerwenka
1 reference
Ernst Kubista
1 reference
Johannes Attems
1 reference
Ruth Müller
1 reference
Daphne Gschwantler-Kaulich
1 reference
Mahmood Manavi
1 reference
Isabell Huber
1 reference
Heinz Hoschützky
1 reference
Christoph C Zielinski
1 reference
Christian F Singer
1 reference
1 March 2006
1 reference
1 reference
118
1 reference
5
1 reference
1126-1134
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference